EverHint – Dip & Bounce Mean Reversion Signals for Jan 12, 2026 – Healthcare Leads with 17 Setups
What This Signal Is (Quick)
This strategy identifies stocks that experienced a controlled intraday flush followed by a same-day bounce, creating a classic "dip & bounce" pattern:
- Signal Type (DIP_BOUNCE_LONG): Buy-side signals only (v1)
- Stock dipped meaningfully below previous day's close during today's session
- Stock bounced off the intraday low and closed well above it
- Day often finishes red or flat, but with a clear lower tail/wick showing buyers stepped in
Pattern Requirements:
- Dip vs Previous Close: Today's low trades significantly below yesterday's close (≥1.5% dip)
- Bounce Off Low: Price recovers intraday and closes meaningfully above the session low (≥0.75% bounce)
- Net Result: Stock still often down or flat for the day (-2.5% to +0.5%), but with visible buying pressure
Key Characteristics:
- Mean reversion focus (not trend following)
- Targets 1-3 day bounce plays or short-term swing trades
- Looks for "flush then absorb" patterns with controlled selloffs
- Complements trend-following strategies (EMA crossovers) by catching short-term dips
Best For:
- Traders who like buying controlled dips with visible buying pressure
- Scanning for intraday flush patterns across the whole market
- Manually picking 1-2 best setups for short-term trades
Key Criteria:
-
Minimum dip: 3.3% (open to intraday low)
-
Minimum bounce: 1.0% from low
-
Net change range: -2.0% to +0.3%
-
Price above SMA(200)
-
Minimum ADV: $40M
Holding Period: 1-5 days
Risk Level: Medium
How We Ranked Today
Ranked by dip magnitude (highest first)
📊 Dip & Bounce Mean Reversion Signals (Top 15 of 36 total)
Ranked by dip_percent:
| Rank | Ticker | Company | Sector | Last ($) | Dip % | Bounce % | Net % | RSI14 | Insider Net | Days → Earnings | Est EPS | Mkt Cap ($B) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CRML | Critical Metals Corp. | Basic Materials | 14.76 | 8.2% | 7.4% | -1.44% | 54.2 | — | — | $1.10 | 1.4 |
| 2 | BBIO | BridgeBio Pharma, Inc. | Healthcare | 76.84 | 8.2% | 8.3% | -0.53% | 51.8 | $-7.6M | 38 | $6.35 | 14.6 |
| 3 | OUST | Ouster, Inc. | Technology | 27.32 | 7.8% | 6.3% | -1.97% | 77.5 | $-224K | 66 | $0.42 | 1.6 |
| 4 | PTCT | PTC Therapeutics, Inc. | Healthcare | 77.59 | 7.6% | 8.3% | 0.08% | 43.5 | $-5.8M | 45 | $4.82 | 6.2 |
| 5 | HOUS | Anywhere Real Estate Inc. | Real Estate | 17.64 | 7.3% | 7.9% | 0.00% | 83.2 | — | 31 | $0.67 | 2.0 |
| 6 | TVTX | Travere Therapeutics, ... | Healthcare | 34.10 | 6.7% | 5.7% | -1.39% | 48.9 | $-7.2M | 38 | $4.19 | 3.1 |
| 7 | MRNA | Moderna, Inc. | Healthcare | 33.84 | 5.6% | 4.5% | -1.34% | 50.1 | $-703K | 32 | $-0.44 | 13.2 |
| 8 | OSCR | Oscar Health, Inc. | Healthcare | 17.66 | 4.9% | 4.7% | -0.39% | 80.1 | — | 22 | $1.07 | 4.5 |
| 9 | BRKR | Bruker Corporation | Healthcare | 53.41 | 4.8% | 3.1% | -1.93% | 76.9 | — | 31 | $3.10 | 8.1 |
| 10 | MLYS | Mineralys Therapeutics... | Healthcare | 32.98 | 4.6% | 3.6% | -1.17% | 24.8 | $-48.0M | 30 | $1.83 | 2.2 |
| 11 | AMKR | Amkor Technology, Inc. | Technology | 51.58 | 4.6% | 3.4% | -1.36% | 78.8 | — | 28 | $2.50 | 12.8 |
| 12 | HSIC | Henry Schein, Inc. | Healthcare | 76.13 | 4.6% | 2.8% | -1.94% | 43.9 | — | 43 | $6.54 | 9.3 |
| 13 | EXEL | Exelixis, Inc. | Healthcare | 44.06 | 4.5% | 4.8% | 0.05% | 49.0 | $-8.8M | 29 | $5.60 | 11.8 |
| 14 | RVMD | Revolution Medicines, ... | Healthcare | 117.17 | 4.5% | 3.4% | -1.24% | 91.5 | $-3.1M | 44 | $0.08 | 22.7 |
| 15 | UAA | Under Armour, Inc. | Consumer Cyclical | 5.60 | 4.4% | 3.9% | -0.71% | 68.3 | — | 24 | $0.23 | 2.4 |
Field Notes
Sector concentration: Healthcare (17), Consumer Cyclical (8), Industrials (3)
Average metrics: 4.6% dip, 3.9% bounce. V-shaped recoveries suggest buying pressure at lows.
Insider selling: ALL (Allstate Corporation (The), $-5.4M), APGE (Apogee Therapeutics, Inc., $-4.9M), PTCT (PTC Therapeutics, Inc., $-5.8M)
Data coverage: 41.7% insider, 97.2% earnings, 100.0% analyst, 19.4% news
Recent Headlines
AMKR (Amkor Technology, Inc.)
- Amkor Technology (AMKR) Increases Despite Market Slip: Here's What You Need to Know (source)
- Allspring Global Investments Holdings LLC Takes $6.71 Million Position in Amkor Technology, Inc. $AMKR (source)
- Amkor Stock Up 12% In A Day - What's Happening? (source)
- Amkor Technology (AMKR) Soars 12.1%: Is Further Upside Left in the Stock? (source)
HOUS (Anywhere Real Estate Inc.)
- Largest Real Estate Names Spike On Merger Talk As Trump Rattles Market (source)
- Anywhere Real Estate (HOUS) Stock Jumps 17.9%: Will It Continue to Soar? (source)
- Compass and Anywhere Stockholders Overwhelmingly Approve Merger (source)
- Coldwell Banker Realty's Dawn McKenna Group Expands to 30A Amid Growing Demand in Florida's Emerald Coast (source)
- Sotheby's International Realty Releases 2026 Luxury Outlook Report, Shows Luxury Residences Leading The Year's Real Estate Market (source)
RVMD (Revolution Medicines, Inc.)
- Merck in talks to buy biotech Revolution Medicines, FT reports (source)
- RVMD Stock Hits a Record High on Rumored Takeover Interest (source)
- Revolution Medicines Announces FDA Breakthrough Therapy Designation for Zoldonrasib (source)
- AbbVie Denies It's in Talks to Buy Revolution Medicines. Both Stocks Are Falling. (source)
- Breakfast News: Defense Stocks Whipsaw (source)
- Why Revolution Medicines Shares Are Sliding After Hours On Wednesday (source)
- AbbVie in talks to buy biotech Revolution Medicines, WSJ reports (source)
- AbbVie Near Deal for Revolution Medicines (source)
- Revolution Medicines to Present at 44th Annual J.P. Morgan Healthcare Conference (source)
Market Context
Broad market indices are exhibiting modest gains, with the S&P 500 up 0.48%, Nasdaq advancing 0.67%, and Dow Jones rising 0.18%, signaling a steady uptrend and healthy risk appetite among investors. This environment supports dip bounce strategies, as pullbacks within an overall positive momentum are more likely to recover quickly, providing reliable entry points for the 36 signals generated. The dip bounce approach thrives here, capitalizing on temporary retracements in a bullish backdrop rather than fighting against deeper corrections.
The VIX at 15.12, down sharply by 5.85%, reflects subdued volatility, which tempers intraday swings and reduces the magnitude of dips. While this may result in shallower pullbacks—potentially limiting the upside explosiveness of bounces—it enhances the precision of signals by minimizing whipsaws and false breakdowns. Traders can approach these opportunities with tighter risk management, as the low-volatility regime favors controlled rebounds over erratic movements.
With healthcare emerging as the top sector amid 36 total signals, sector rotation appears tilted toward defensive areas, even as broader indices climb. This dynamic bolsters dip bounce efficacy in healthcare, where dips may attract value-seeking flows in a risk-on climate, but it warrants caution for overexposure if rotation accelerates away from cyclicals. Overall, current conditions align favorably for selective dip bounces, prioritizing sectors showing relative strength.
Vlad's Take (EverHint)
Today's signals: Strong sector concentration in Healthcare (17 signals) suggests sector-specific rotation. 15 signals showing insider selling warrant caution. Maximum dip of 8.2% offers meaningful entry discount. Above-average dips (4.6%) suggest elevated volatility.
Trading tips for this strategy:
- Entry timing: Consider entering on next-day weakness or at previous day's close level
- Position sizing: Start small (1-2% of portfolio per signal)
- Stop loss: Below today's low (tight stops for mean reversion)
- Take profit: 3-5% bounce target, or previous day's high
- Time stop: Exit if no bounce in 1-3 days
Risk warning: Mean reversion can fail in strong downtrends - check broader market context
Sharing Call-to-Action
📈 Enjoying the updates? Liking, sharing, or subscribing helps bring this analysis to a wider audience.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/